Wellgistics Health, a U.S.-based pharmaceutical distributor, has secured a $50 million credit line to build a blockchain-based payment system using XRP. The goal is to streamline healthcare transactions by connecting manufacturers, pharmacies, and patients on one fast, transparent platform.
CEO Brian Norton says this shift will eliminate delays and inefficiencies in healthcare payments. XRP was chosen for its speed, low cost, and global reach. The company plans to use it for real-time payments, rebates, credit lines, and more.
In a bold move, Wellgistics also announced it will adopt XRP as a treasury reserve asset—making it the first public company to do so. This decision was influenced by XRP’s growing legitimacy, including its futures launch on CME and Mastercard's support for its use in cross-border payments.
Despite the news, Wellgistics’ stock (WGRX) dropped over 30% and now trades at $2.87. Meanwhile, XRP has surged nearly 10%, boosted by a market rally and Ripple’s partial legal victory over the SEC, settling a long-standing lawsuit for $50 million.